Evidence map›Paper›PMID 32252256›Full record

ArticleJournal of clinical medicine2020

Brain Circuit Alterations and Cognitive Disability in Late-Onset Cobalamin D Disorder.

Javier De Las Heras, Ibai Diez, Antonio Jimenez-Marin, Alberto Cabrera, Daniela Ramos-Usuga, Marta Venecia Diaz-Fernandez, Leire Torices, Caroline E Nunes-Xavier, Rafael Pulido, Juan Carlos Arango-Lasprilla and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 3 countries.

Javier De Las HerasDivision of Pediatric Metabolism, Cruces University Hospital, 48903 Barakaldo, Spain.ORCID 0000-0001-5663-537X
Ibai DiezGordon Center for Medical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02115, USA.ORCID 0000-0001-5769-0178
Antonio Jimenez-MarinComputational Neuroimaging Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-6053-6101
Alberto CabreraOsatek, 48011 Vitoria-Gazteiz, Spain.
Daniela Ramos-UsugaBiomedical Research Doctorate Program, University of the Basque Country (UPV/EHU), 48940 Leioa, Spain.ORCID 0000-0002-4803-2760
Marta Venecia Diaz-FernandezDivision of Pediatric Metabolism, Cruces University Hospital, 48903 Barakaldo, Spain.
Leire ToricesBiomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Caroline E Nunes-XavierBiomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-1875-6645
Rafael PulidoBiomarkers in Cancer Unit, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Juan Carlos Arango-LasprillaBiocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.
Jesus M CortesComputational Neuroimaging Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.ORCID 0000-0002-9059-8194
Ikerbasque · ESUniversity of the Basque Country · ESBioCruces Health research Institute · ESHarvard University · USHospital de Cruces · ESOsakidetza · ESOslo University Hospital · NO

Funding

Ministerio de Economía, Industria y Competitividad, Gobierno de España DPI2016-79874-R
6 · The paper itself

Abstract

Neuroimaging studies describing brain circuits' alterations in cobalamin (vitamin B12)-deficient patients are limited and have not been carried out in patients with inborn errors of cobalamin metabolism. The objective of this study was to assess brain functionality and brain circuit alterations in a patient with an ultra-rare inborn error of cobalamin metabolism, methylmalonic aciduria, and homocystinuria due to cobalamin D disease, as compared with his twin sister as a healthy control (HC). We acquired magnetic resonance imaging (including structural, functional, and diffusion images) to calculate brain circuit abnormalities and combined these results with the scores after a comprehensive neuropsychological evaluation. As compared with HC, the patient had severe patterns of damage, such as a 254% increment of ventricular volume, pronounced subcortical and cortical atrophies (mainly at striatum, cingulate cortex, and precuneus), and connectivity alterations at fronto-striato-thalamic circuit, cerebellum, and corpus callosum. In agreement with brain circuit alterations, cognitive deficits existed in attention, executive function, inhibitory control, and mental flexibility. This is the first study that provides the clinical, genetic, neuroanatomical, neuropsychological, and psychosocial characterization of a patient with the cobalamin D disorder, showing functional alterations in central nervous system motor tracts, thalamus, cerebellum, and basal ganglia, that, as far as we know, have not been reported yet in vitamin B12-related disorders.

Indexed as

cobalamincobalamin D diseasecognitive functioningdiffusion imagingfunctional neuroimagingmethylmalonic aciduria and homocystinuriaresting statevitamin B12

Identifiers

PMID32252256
PMCPMC7231091
OpenAlexW3015015561

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.